130 related articles for article (PubMed ID: 31538980)
41. Oral fluoropyrimidines: a closer look at their toxicities.
Macdonald JS
Am J Clin Oncol; 1999 Oct; 22(5):475-80. PubMed ID: 10521062
[TBL] [Abstract][Full Text] [Related]
42. [Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
Tichler T; Ghodsizade E; Katz A; Rath P; Berger R; Brenner H
Harefuah; 1999 Nov; 137(9):387-90, 430. PubMed ID: 11419042
[TBL] [Abstract][Full Text] [Related]
43. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
44. Infusion pumps for systemic and intra-arterial chemotherapy of colorectal liver metastases.
Howell JD; Gallagher H; Kane E; Maguire R; McArdle CS
Ann R Coll Surg Engl; 1997 Jul; 79(4):257-8. PubMed ID: 9244067
[TBL] [Abstract][Full Text] [Related]
45. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
46. Capecitabine Versus Continuous Infusion Fluorouracil for the Treatment of Advanced or Metastatic Colorectal Cancer: a Meta-analysis.
Wu Z; Deng Y
Curr Treat Options Oncol; 2018 Nov; 19(12):77. PubMed ID: 30483908
[TBL] [Abstract][Full Text] [Related]
47. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
Francis N
Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
[TBL] [Abstract][Full Text] [Related]
48. Continuous infusion 5-fluorouracil as salvage chemotherapy in patients with advanced colorectal cancer.
Lim WT; Koo WH; Au E; Khoo KS
Ann Acad Med Singap; 1999 Mar; 28(2):256-9. PubMed ID: 10497678
[TBL] [Abstract][Full Text] [Related]
49. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
Yeh KH; Cheng AL
Br J Cancer; 1997; 75(3):464-5. PubMed ID: 9020500
[No Abstract] [Full Text] [Related]
50. Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors.
Grem JL; Harold N; Shapiro J; Bi DQ; Quinn MG; Zentko S; Keith B; Hamilton JM; Monahan BP; Donavan S; Grollman F; Morrison G; Takimoto CH
J Clin Oncol; 2000 Dec; 18(23):3952-63. PubMed ID: 11099325
[TBL] [Abstract][Full Text] [Related]
51. Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma.
Wang TL; Tan YO
Ann Acad Med Singap; 1991 Sep; 20(5):601-3. PubMed ID: 1781642
[TBL] [Abstract][Full Text] [Related]
52. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group study.
Berenberg JL; Tangen C; Macdonald JS; Hutchins LF; Natale RB; Oishi N; Guy JT; Fleming TR
Cancer; 1995 Sep; 76(5):715-9. PubMed ID: 8625171
[TBL] [Abstract][Full Text] [Related]
55. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
56. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
Crawley C; Ross P; Norman A; Hill A; Cunningham D
Br J Cancer; 1998 Aug; 78(4):508-10. PubMed ID: 9716035
[TBL] [Abstract][Full Text] [Related]
57. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion.
Chiara S; Nobile MT; Barzacchi C; Sanguineti O; Vincenti M; Di Somma C; Meszaros P; Rosso R
Eur J Cancer; 1997 May; 33(6):967-9. PubMed ID: 9291822
[TBL] [Abstract][Full Text] [Related]
58. Symptomatic cardiotoxicity associated with 5-fluorouracil.
Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
[TBL] [Abstract][Full Text] [Related]
59. [pericarditis following 5-fluorouracil administration].
Maréchal S; Racaru V; Houbiers G; Graas MP
Rev Med Liege; 2015; 70(7-8):360-6. PubMed ID: 26376561
[TBL] [Abstract][Full Text] [Related]
60. 5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer.
Rougier P; Paillot B; LaPlanche A; Morvan F; Seitz JF; Rekacewicz C; Laplaige P; Jacob J; Grandjouan S; Tigaud JM; Fabri MC; Luboinski M; Ducreux M
Eur J Cancer; 1997 Oct; 33(11):1789-93. PubMed ID: 9470834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
